Abstract
Objective: The occurrence of autoimmune diseases or deterioration of pre-existing disorders has recently been described after cytokine treatment. The present report gives evidence for acquired myasthenia gravis induced by externally administered interferon-α and interleukin-2 in a patient with metastasized renal cell carcinoma. Electromyographic investigations did not reveal generalised myasthenia gravis. However, a highly elevated titre of antibodies against the human acetylcholine receptor and a significant improvement in clinical symptoms during therapy with anticholinesterase drugs, combined with a decremental response in electronystagmography, indicated an intermittent mainly oculo-bulbar form of myasthenia gravis.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: 9 October 1995/Accepted in revised form: 15 January 1996
Rights and permissions
About this article
Cite this article
Rohde, D., Sliwka, U., Schweizer, K. et al. Oculo-bulbar myasthenia gravis induced by cytokine treatment of a patient with metastasized renal cell carcinoma. E J Clin Pharmacol 50, 471–473 (1996). https://doi.org/10.1007/s002280050143
Issue Date:
DOI: https://doi.org/10.1007/s002280050143